Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian

Abstract The characterization of immunological and genomic differences in small-cell lung cancer (SCLC) between East Asian (EA) and Caucasian patients can reveal important clinical therapies for EA patients with SCLC. By sequencing and analyzing a molecular and immunological dataset of 98-SCLC patie...

Full description

Bibliographic Details
Main Authors: Anqi Lin, Ningning Zhou, Weiliang Zhu, Jiexia Zhang, Ting Wei, Linlang Guo, Peng Luo, Jian Zhang
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Cancer Cell International
Subjects:
Online Access:https://doi.org/10.1186/s12935-022-02588-w
_version_ 1818266848075972608
author Anqi Lin
Ningning Zhou
Weiliang Zhu
Jiexia Zhang
Ting Wei
Linlang Guo
Peng Luo
Jian Zhang
author_facet Anqi Lin
Ningning Zhou
Weiliang Zhu
Jiexia Zhang
Ting Wei
Linlang Guo
Peng Luo
Jian Zhang
author_sort Anqi Lin
collection DOAJ
description Abstract The characterization of immunological and genomic differences in small-cell lung cancer (SCLC) between East Asian (EA) and Caucasian patients can reveal important clinical therapies for EA patients with SCLC. By sequencing and analyzing a molecular and immunological dataset of 98-SCLC patients of EA ancestry, immunogenicity, including DNA damage repair alterations and tumor mutation burden (TMB), was found to be significantly higher in the EA cohort than in the Caucasian cohort. The epithelial-mesenchymal transition (EMT) was the signaling signature with the predominant frequency of mutations across all patients in the EA cohort. Analysis of tumor-infiltrated immune cells revealed that resting lymphocytes were significantly enriched in the EA cohort. Compound-targeting analysis showed that topoisomerase inhibitors might be capable of targeting TP53 and RB1 comutations in EA SCLC patients. EA SCLC patients who harbored COL6A6 mutations had poor survival, while Caucasian SCLC patients with OTOF, ANKRD30B, and TECPR2 mutations were identified to have a shorter survival.
first_indexed 2024-12-12T20:13:13Z
format Article
id doaj.art-a479861fe7c64f5daf01a52c0b10ae36
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-12T20:13:13Z
publishDate 2022-04-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-a479861fe7c64f5daf01a52c0b10ae362022-12-22T00:13:28ZengBMCCancer Cell International1475-28672022-04-0122111610.1186/s12935-022-02588-wGenomic and immunological profiles of small-cell lung cancer between East Asians and CaucasianAnqi Lin0Ningning Zhou1Weiliang Zhu2Jiexia Zhang3Ting Wei4Linlang Guo5Peng Luo6Jian Zhang7Department of Oncology, Zhujiang Hospital, Southern Medical UniversityDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer CenterDepartment of Oncology, Zhujiang Hospital, Southern Medical UniversityDepartment of Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory DiseaseDepartment of Oncology, Zhujiang Hospital, Southern Medical UniversityDepartment of Pathology, Zhujiang Hospital, Southern Medical UniversityDepartment of Oncology, Zhujiang Hospital, Southern Medical UniversityDepartment of Oncology, Zhujiang Hospital, Southern Medical UniversityAbstract The characterization of immunological and genomic differences in small-cell lung cancer (SCLC) between East Asian (EA) and Caucasian patients can reveal important clinical therapies for EA patients with SCLC. By sequencing and analyzing a molecular and immunological dataset of 98-SCLC patients of EA ancestry, immunogenicity, including DNA damage repair alterations and tumor mutation burden (TMB), was found to be significantly higher in the EA cohort than in the Caucasian cohort. The epithelial-mesenchymal transition (EMT) was the signaling signature with the predominant frequency of mutations across all patients in the EA cohort. Analysis of tumor-infiltrated immune cells revealed that resting lymphocytes were significantly enriched in the EA cohort. Compound-targeting analysis showed that topoisomerase inhibitors might be capable of targeting TP53 and RB1 comutations in EA SCLC patients. EA SCLC patients who harbored COL6A6 mutations had poor survival, while Caucasian SCLC patients with OTOF, ANKRD30B, and TECPR2 mutations were identified to have a shorter survival.https://doi.org/10.1186/s12935-022-02588-wSCLCEast AsianCaucasianGenomicImmune-infiltrating
spellingShingle Anqi Lin
Ningning Zhou
Weiliang Zhu
Jiexia Zhang
Ting Wei
Linlang Guo
Peng Luo
Jian Zhang
Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian
Cancer Cell International
SCLC
East Asian
Caucasian
Genomic
Immune-infiltrating
title Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian
title_full Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian
title_fullStr Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian
title_full_unstemmed Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian
title_short Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian
title_sort genomic and immunological profiles of small cell lung cancer between east asians and caucasian
topic SCLC
East Asian
Caucasian
Genomic
Immune-infiltrating
url https://doi.org/10.1186/s12935-022-02588-w
work_keys_str_mv AT anqilin genomicandimmunologicalprofilesofsmallcelllungcancerbetweeneastasiansandcaucasian
AT ningningzhou genomicandimmunologicalprofilesofsmallcelllungcancerbetweeneastasiansandcaucasian
AT weiliangzhu genomicandimmunologicalprofilesofsmallcelllungcancerbetweeneastasiansandcaucasian
AT jiexiazhang genomicandimmunologicalprofilesofsmallcelllungcancerbetweeneastasiansandcaucasian
AT tingwei genomicandimmunologicalprofilesofsmallcelllungcancerbetweeneastasiansandcaucasian
AT linlangguo genomicandimmunologicalprofilesofsmallcelllungcancerbetweeneastasiansandcaucasian
AT pengluo genomicandimmunologicalprofilesofsmallcelllungcancerbetweeneastasiansandcaucasian
AT jianzhang genomicandimmunologicalprofilesofsmallcelllungcancerbetweeneastasiansandcaucasian